Illumina

YTD

ALL

Trade Illumina 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ILMN

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. The company was founded by David R.

CEO

Jacob Thaysen

CEOJacob Thaysen

Employees

8,600

Employees8,600

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1998

Founded1998

Employees

8,600

Employees8,600

ILMN Key Statistics

Market cap

20.62B

Market cap20.62B

Price-Earnings ratio

24.64

Price-Earnings ratio24.64

Dividend yield

—

Dividend yield—

Average volume

1.55M

Average volume1.55M

High today

$136.63

High today$136.63

Low today

$126.29

Low today$126.29

Open price

$130.34

Open price$130.34

Volume

2.77M

Volume2.77M

52 Week high

$155.53

52 Week high$155.53

52 Week low

$73.86

52 Week low$73.86

Stock Snapshot

With a market cap of 20.62B, Illumina(ILMN) trades at $135.50. The stock has a price-to-earnings ratio of 24.64.

As of 2026-05-02, Illumina(ILMN) stock has fluctuated between $126.29 and $136.63. The current price stands at $135.50, placing the stock +7.3% above today's low and -0.8% off the high.

Illumina(ILMN) shares are trading with a volume of 2.77M, against a daily average of 1.55M.

In the last year, Illumina(ILMN) shares hit a 52-week high of $155.53 and a 52-week low of $73.86.

ILMN News

Simply Wall St 2h

Illumina One Off Gain Shapes Profitability Narrative Heading Into 2026 Earnings

Illumina (ILMN) opened 2026 with Q1 revenue of US$1,091 million and basic EPS of US$0.88, setting the tone for how the year is starting to shape up after its re...

Simply Wall St 1d

Is It Time To Reassess Illumina After Its Sharp One Year Share Price Rebound

Wondering if Illumina at US$126.74 is offering value or just noise after a big rebound? This breakdown will help you frame that question clearly. The stock has...

TipRanks 1d

Illumina price target raised to $125 from $120 at JPMorgan

JPMorgan analyst Casey Woodring raised the firm’s price target on Illumina (ILMN) to $125 from $120 and keeps a Neutral rating on the shares. Unlock hedge fund...

Analyst ratings

48%

of 23 ratings

Buy

47.8%

Hold

39.1%

Sell

13%

More ILMN News

The Motley Fool 2d

Illumina Q1 2026 Earnings Transcript

Image source: The Motley Fool. Thursday, Apr. 30, 2026 at 4:30 p.m. ET Call participants Chief Executive Officer — Jacob Thaysen Chief Financial Officer — Anku...

TipRanks 2d

Illumina lifts 2026 outlook and expands share buybacks

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Simply Wall St 5d

Illumina Valuation Check After DRAGEN v4.5 Launch And Pediatric Genomics Partnership

Advertisement Why Illumina’s latest software launch matters for shareholders Illumina (ILMN) has put its DRAGEN v4.5 software release and a large pediatric ge...

People also own

Based on the portfolios of people who own ILMN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.